Abstract Background: Alopecia areata is a common autoimmune hair‑loss disorder, but alopecia totalis in children can be particularly refractory to conventional topical therapy. Janus kinase (JAK) inhibitors such as tofacitinib have shown promising results in adults, but pediatric data remain limited. Case presentation: We report a 4‑year‑old boy who presented...
Tofacitinib‑Induced Rapid Hair Regrowth in a 4‑Year‑Old Boy with Alopecia Totalis: A Case Report
